Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Angle (AGL) Share News

3456789101112

Angle Reports Positive Study Results For Parsortix System

4th Sep 2019 14:09

(Alliance News) - Angle PLC on Wednesday noted positive results from a study of its Parsortix system in small cell lung cancer.Parsortix is Angle's liquid biopsy technology, meaning it Read More

Angle Ovarian Cancer Testing Platform Study Enrols First Patients

29th Aug 2019 10:57

(Alliance News) - Liquid biopsy firm Angle PLC said Thursday the first patients for its ovarian cancer test study have been enrolled ahead of anticipated completion early in 2020.The study Read More

Angle's Parsortix Used For Analysis Of Circulating Tumor Cells

22nd Jul 2019 12:53

(Alliance News) - Angle PLC on Monday said one of its leading customers, the Disseminated Cancer Cell Network, has published new results of work done to develop a "robust, reliable and for of Read More

Angle's Parsortix Successfully Investigates Immunotherapy Target

21st Jun 2019 12:56

(Alliance News) - Angle PLC on Friday said its Parsortix system has been successfully used as a liquid biopsy to investigate an immunotherapy target in lung cancer.Shares in Angle were up a Read More

Angle's Parsortix And HyCEAD Ziplex Systems Identify Cancer In Study

5th Jun 2019 13:04

LONDON (Alliance News) - Angle PLC on Wednesday announced positive results from a study evaluating the ability of its Parsortix and HyCEAD Ziplex platforms to test for ovarian cancer.The to Read More

Angle's Parsortix System Used In Further "Groundbreaking" Research

26th Apr 2019 12:29

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said its Parsortix system has been used in "groundbreaking" cancer research.The research showed the first the time Read More

US Cancer Centre Uses Angle's Parsortix System For Assessments

18th Apr 2019 11:35

LONDON (Alliance News) - Angle PLC on Thursday said its ParsortixTM system was used by the University of Texas MD Anderson Cancer Center to develop a new technique for assessing the metastatic of Read More

University Of Athens Cancer Study To Use Angle's Parsortix System

12th Apr 2019 11:59

LONDON (Alliance News) - Liquid biopsy firm Angle PLC on Friday said a "leading" customer has set up a multi-centre study using its Parsortix system.The study is being carried out Read More

Angle Enrols All 400 Patients In US Breast Cancer Study For Parsortix

7th Mar 2019 13:09

LONDON (Alliance News) - Angle PLC on Thursday said it has completed enrolment for a US study of its Parsortix biopsy technology in metastatic breast cancer.All of the 400 subjects required Read More

Angle Enrolls First Patients In Ovarian Cancer Study

28th Feb 2019 13:30

LONDON (Alliance News) - Angle PLC on Thursday said it has enrolled the first patients in an ovarian cancer verification study, after receiving ethics approval.The study will be divided a a Read More

Angle Reports Widened Interim Loss On Higher Operating Costs

31st Jan 2019 12:04

LONDON (Alliance News) - Angle PLC on Thursday reported a widened interim loss on an increase operating costs.In the six months to October 31, the tumour cell researcher said its pretax to Read More

UK Earnings, Trading Statements Calendar - Next 7 Days

24th Jan 2019 15:58

Friday 25 January BonmarcheTrading Statement AG BarrTrading GroupQ3 Smaller Read More

Angle Shares Jump As Parsortix System Used In New Cancer Treatment

10th Jan 2019 17:05

LONDON (Alliance News) - Angle PLC shares spiked late Thursday afternoon after the company said its Partsortix system will be used in "ground-breaking" new cancer research.Shares Read More

ANGLE To Acquire Remaining Stake In US Subsidiary For GBP467,500 (ALLISS)

5th Nov 2018 12:11

LONDON (Alliance News) - Liquid biopsy company ANGLE PLC said on Monday it has agreed to acquire the remaining shares in US subsidiary ANGLE North America Inc it does not own from Parsotix Georgi Read More

Angle Appoints Cancer Diagnostic Firm Chief As Non-Executive Director

1st Nov 2018 14:09

LONDON (Alliance News) - Biopsy company Angle PLC said Thursday it has appointed the President of Euronext-listed cancer diagnostics firm MDxHealth to its board.Jan Groen joins the board of Read More

Angle Pilot Study Shows Promise Of Parsortix In Prenatal Testing

29th Oct 2018 11:27

LONDON (Alliance News) - Liquid biopsy company Angle PLC on Monday said it has received positive results from a study examining the use of its Parsortix system in prenatal testing.Shares in Read More

Angle Nearing Completion Of Patient Enrolment Breast Cancer Study

25th Oct 2018 12:55

LONDON (Alliance News) - Liquid biopsy firm Angle PLC said it is making good progress on recruiting patients for its ANG-002 clinical study.The study is focusing on a treatment for breast a Read More

UK Shareholder Meetings Calendar - Next 7 Days

23rd Oct 2018 15:59

Wednesday 24 OctoberIndigovisionBeeks FinancialReddePhoto-Me 25 & Smart 26 29 30 Read More

Angle's Parsortix System Able To Identify Tumour Cells In Glioblastoma

28th Aug 2018 14:17

LONDON (Alliance News) - Angle PLC on Tuesday said researchers at the Cancer Metastasis Laboratory, located at the University of Basel, have provided evidence of circulating tumour cell clusters a Read More

ANGLE Appoints Urological Surgeon Greg Shaw As Scientific Advisor

14th May 2018 12:17

LONDON (Alliance News) - ANGLE PLC said Monday it appointed urological surgeon, Greg Shaw, as a scientific advisor.The liquid biopsy company appointed the prostate cancer UK National Health Read More

3456789101112
FTSE 100 Latest
Value8,295.79
Change20.13